Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?

被引：0
|
作者：
Eid M. El-Shafey
Said H. Abdou
Mohamed M. Shareef
机构：
[1] Tanta University Hospitals,Division of Nephrology, Department of Internal Medicine
[2] Tanta University,Department of Clinical Pathology
[3] Tanta University,Department of Pathology, Faculty of Medicine
[4] Tanta University,undefined
来源：
Clinical and Experimental Nephrology | 2010年 / 14卷
关键词：
Intravenous cyclophosphamide (IVC); Mycophenolate mofetil; Proliferative lupus nephritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：214 / 221
页数：7
相关论文
共 50 条
  • [41] Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis
    Smith, E. M. D.
    Al-Abadi, E.
    Armon, K.
    Bailey, K.
    Ciurtin, C.
    Davidson, J.
    Gardner-Medwin, J.
    Haslam, K.
    Hawley, D.
    Leahy, A.
    Leone, V.
    McErlane, F.
    Mewar, D.
    Modgil, G.
    Moots, R.
    Pilkington, C.
    Ramanan, A.
    Rangaraj, S.
    Riley, P.
    Sridhar, A.
    Wilkinson, N.
    Beresford, M. W.
    Hedrich, C. M.
    [J]. LUPUS, 2019, 28 (05) : 613 - 620
  • [42] INTRAVENOUS PULSE CYCLOPHOSPHAMIDE THERAPY IN SEVERE LUPUS NEPHRITIS
    FRUTOS, MA
    RIVILLA, A
    GARCIA, I
    BURGOS, D
    VALERA, A
    MARTINREYES, G
    CABELLO, M
    DENOVALES, EL
    [J]. NEFROLOGIA, 1990, 10 : 88 - 93
  • [43] Mycophenolate mofetil therapy in patients with cyclophosphamide- (CyP) resistant or relapsing diffuse proliferative lupus nephritis (SLE-DPGN).
    Nachman, PH
    Dooley, MA
    Hogan, SL
    Aiello, JR
    Jennette, JC
    Falk, RJ
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0448 - A0448
  • [44] Mycophenolate mofetil seems to be superior to Azothioprine in Maintenance therapy of Lupus nephritis
    Schmalzing, M.
    Koetter, I.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2012, 71 (09): : 813 - 815
  • [45] Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis - Reply
    Chan, TM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (05): : 383 - 383
  • [46] Multicenter controlled trial of mycophenolate mofetil (MMF) vs. intravenous cyclophosphamide (IVC) as induction therapy for severe lupus nephritis (LN)
    Appel, G
    Ginzler, E
    Radhakrishnan, J
    Aranow, C
    Buyon, J
    Dooley, M
    Merrill, J
    Petri, M
    Gilkeson, G
    Wallace, D
    Weisman, M
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 38A - 38A
  • [47] Toxicity and tolerability of mycophenolate mofetil (MMF) vs. intravenous cyclophosphamide (IVC) in a multicenter trial as induction therapy for lupus nephritis (LN).
    Ginzler, EM
    Aranow, C
    Merrill, JT
    Orloff, K
    Henry, D
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S586 - S587
  • [48] Identification of Biomarkers That Predict Response to Treatment of Lupus Nephritis With Mycophenolate Mofetil or Pulse Cyclophosphamide
    Dall'Era, Maria
    Stone, David
    Levesque, Victoria
    Cisternas, Miriam
    Wofsy, David
    [J]. ARTHRITIS CARE & RESEARCH, 2011, 63 (03) : 351 - 357
  • [49] Mycophenolate mofetil (MPA) versus intravenous cyclophosphamide (IVCYP) in the remission of lupus nephritis (LN)
    Goh, S. M.
    Tan, T.
    Tan, S. H.
    Liew, A.
    [J]. NEPHROLOGY, 2008, 13 : A50 - A50
  • [50] Mycophenolate mofetil as induction and maintance therapy of lupus nephritis - our experience
    Raskovic, S.
    Peric-Popadic, A.
    Jovicic, Z.
    Tomic-Spiric, V
    Sojic-Rajcic, J.
    Stefanovic, L.
    Bogic, M.
    [J]. ALLERGY, 2010, 65 : 464 - 464
12345